GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP — Class II drug recall D-1293-2014
Terminated recall by Teva Pharmaceuticals USA, reported 2014-05-21, distributed nationwide. CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
| Recall number | D-1293-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Horsham, PA, United States |
| Recall initiated | 2014-03-24 |
| Classified | 2014-05-12 |
| Reported by FDA | 2014-05-21 |
| Terminated | 2014-11-14 |
| Distributed | Nationwide (US) |
| Quantity | 2,532 bottles |
| Reason classes | cgmp |
| NDC | 00093-5712-05 |
Product
GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC: 0093-5712-05
Reason for recall
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1293-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.